University Study Shows Pradaxa Could Increase Viral Infection Risk, Notes Rottenstein Law Group

The Rottenstein Law Group, a Pradaxa law firm, acknowledges the study and maintains its Pradaxa page at http://www.rotlaw.com/pradaxa-lawsuit/, which illustrates in detail the options for those who believe the drug has harmed them.

  • Share on TwitterShare on FacebookShare on Google+Share on LinkedInEmail a friend
Pradaxa lawsuits are being filed all over the United States.

Pradaxa lawsuits are being filed all over the United States.

This is yet another study that could possibly be used in the courtroom to support the claims of those who have been harmed.

(PRWEB) April 17, 2013

The blood thinner Pradaxa, which has alleged excessive bleeding side effects, is now under scrutiny because of another potential risk: viral infections, according to a study conducted by researchers at the University of North Carolina. The Rottenstein Law Group, a Pradaxa law firm, acknowledges the study and maintains its Pradaxa page at http://www.rotlaw.com/pradaxa-lawsuit/, which illustrates in detail the options for those who believe the drug has harmed them.

Pradaxa blocks a key component of the blood-clotting process, according to the study.* An unintended side effect of this is that Pradaxa also inhibits the body’s natural response to viral infection. That means that taking Pradaxa could increase the risk and severity of illnesses like the flu, the study said. The researchers are now determining if the older anticoagulant warfarin has the same side effect.

“We have received phone calls and emails from people who have experienced the potentially serious excessive bleeding side effects of Pradaxa,” said Rochelle Rottenstein, principal of the Rottenstein Law Group. “This is yet another study that could possibly be used in the courtroom to support the claims of the harmed.”

There are a growing number of lawsuits nationwide, many of which have been consolidated into a federal multidistrict litigation (In re Pradaxa Products Liability Litigation, MDL-2385, U.S. District Court for the Southern District of Illinois (East St. Louis)).**

The Rottenstein Law Group represents clients who believe they have been harmed by Pradaxa and encourages people to visit the firm’s Pradaxa Legal Information Center and to download a free brochure to help them determine if they have a case.

*http://www.jci.org/articles/view/66125

**bloomberg.com/news/2012-12-11/boehringer-sued-by-hundreds-over-bleeding-tied-to-pradaxa.html

About THE ROTTENSTEIN LAW GROUP
The Rottenstein Law Group is a New York-based firm that represents clients nationwide in mass tort actions. The firm was founded by Rochelle Rottenstein, who has more than two decades of experience as a lawyer, to represent clients hurt by defective medical devices and medications. (Attorney advertising. Prior results do not guarantee a similar outcome.)

Contact:
The Rottenstein Law Group, LLP
Rochelle Rottenstein, Esq.
321 W. 44th Street
# 804
New York NY 10036
(212) 933-9500 (office phone)
(212) 933-9980 (facsimile)
rochelle (at) rotlaw (dot) com
http://www.rotlaw.com